Neil F. McFarlane - Feb 7, 2025 Form 4 Insider Report for ZEVRA THERAPEUTICS, INC. (ZVRA)

Signature
/s/ Timothy J. Sangiovanni, Attorney-in-Fact for Neil F. McFarlane
Stock symbol
ZVRA
Transactions as of
Feb 7, 2025
Transactions value $
$0
Form type
4
Date filed
2/10/2025, 05:37 PM
Previous filing
Feb 3, 2025
Next filing
Feb 14, 2025

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZVRA Stock Option (right to buy) Award $0 +225K $0.00 225K Feb 7, 2025 Common Stock 225K $7.77 Direct F1
transaction ZVRA Restricted Stock Unit Award $0 +113K $0.00 113K Feb 7, 2025 Common Stock 113K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the "Plan"). The option will vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant.
F2 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F3 The restricted stock units will vest and settle as to one third of the restricted stock units on February 7, 2026, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's continued service through such vesting date.